Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared on LinkedIn:
”Thalassemia is a rare blood disorder that still affects about 7,000 patients in Italy, many of whom depend on lifelong transfusions.
Research has changed the course of this disease in recent decades, but much remains to be done to prevent complications and move closer to a cure.
At the Franco and Piera Cutino Foundation we work every day on research, prevention and innovative therapies, from early prenatal diagnosis to gene therapy and international collaboration on rare hematologic diseases.
In this video I share the mission and the projects we are advancing, also supported by our Easter solidarity campaign ‘Giving makes you happy’.”
Stay updated with Hemostasis Today.
-
Mar 7, 2026, 15:52Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
-
Mar 7, 2026, 15:50Heghine Khachatryan: How DOACs Can Cause False-Positive FVIII Inhibitor Results
-
Mar 7, 2026, 15:43Gevorg Tamamyan Joins The London Global Cancer Week Steering Group
-
Mar 7, 2026, 15:36Kenneth Monaghan: Empowering Stroke Survivors’ Self-Efficacy Through Neuroplasticity and Daily Activity
-
Mar 7, 2026, 15:31Tagreed Alkaltham: Practical Strategies for Navigating Blood Shortage Periods
-
Mar 7, 2026, 15:28Philip Wells Honored with the 2026 ISTH Esteemed Career Award
-
Mar 7, 2026, 15:27Gashaw Arega: A Challenging Case of Acute Immune Thrombocytopenia in an Adolescent
-
Mar 7, 2026, 15:25Worldwide Media Amplifies Call for Equity in Bleeding Disorders Care – WFH
-
Mar 7, 2026, 15:19Jecko Thachil: Can We Use Styptics as Topical Haemostats in Bleeding Disorders